The two flagship targeted allergy drugs for dogs — how each works, the trade-offs, and when each fits.
If your vet has recommended Apoquel or Cytopoint for your dog's allergies, you've probably heard mixed reviews online — from 'life-changing' to 'I'd never put my dog on it.' The actual picture is more measured. Both drugs have legitimate roles, real benefits, and real trade-offs.
We measure success in years, not weeks. Here's a working overview of what each does, where each fits, and what owners should understand before starting either.
Apoquel: what it is
Apoquel (oclacitinib) is an oral medication that blocks JAK (Janus kinase) enzymes involved in inflammatory signaling. It specifically targets pathways that produce itch sensation in dogs.
Approved by the FDA in 2013 for atopic dermatitis and allergic dermatitis in dogs over 12 months. One of the fastest-acting allergy treatments available — most dogs show improvement within 24 hours.
Apoquel: how it works
The JAK pathway is involved in transmitting itch signals from skin to brain. By blocking specific JAK enzymes, Apoquel reduces the dog's perception of itching at the source.
It also reduces inflammation by interrupting cytokine signaling. The net effect is rapid reduction of itch and visible skin inflammation.
Apoquel: trade-offs
Side effects in published trials and clinical experience: occasional GI upset, slight increase in infection susceptibility (because immune signaling is partially dampened), rare elevation in certain blood values.
Long-term safety data continues to accumulate. Most veterinary dermatologists consider long-term Apoquel safe under monitoring (periodic bloodwork). Some owners and vets prefer to limit duration.
Apoquel: when it fits
Best for dogs with moderate to severe atopic dermatitis whose itching significantly impacts quality of life. Excellent for breaking the itch-scratch cycle quickly.
Used either continuously or intermittently for seasonal flares. Some dogs do well on lower maintenance doses; others need full doses during active flare periods.
Cytopoint: what it is
Cytopoint (lokivetmab) is a monoclonal antibody given as an injection — typically every 4-8 weeks. It targets interleukin-31 (IL-31), a cytokine specifically involved in itch sensation in dogs.
Approved in 2016. Highly specific to the itch pathway with minimal systemic effects.
Cytopoint: how it works
IL-31 is the cytokine that transmits 'itch' signals from skin to nerves in atopic dogs. Cytopoint binds and neutralizes IL-31 specifically.
Because it's targeted at one specific molecule, it has fewer broader effects on the immune system than systemic medications.
Cytopoint: trade-offs
Cost — typically more expensive per month than Apoquel. Requires vet visit for injection. Effect duration varies by individual dog (4-8 weeks).
Some dogs respond dramatically; others show partial response. Predicting response in advance isn't currently possible.
Cytopoint: when it fits
Particularly good for dogs whose owners prefer to avoid oral daily medications. Useful for dogs with concurrent conditions that make Apoquel less ideal.
Excellent for dogs whose allergy pattern is seasonal or episodic — the timing of injections can align with high-risk seasons.
Comparing the two
Speed: Apoquel acts within 24 hours; Cytopoint within 1-2 days.
Duration: Apoquel daily; Cytopoint 4-8 weeks per injection.
Side effect profile: Apoquel has broader systemic effects; Cytopoint is more targeted.
Cost: Apoquel monthly cost is usually lower; Cytopoint per-injection cost is higher but spread over weeks.
What both have in common
They suppress the itch response — they don't treat the underlying allergy. The dog still has atopy; the symptoms are managed.
They work better as part of comprehensive care (skin barrier support, allergen avoidance, immunotherapy when appropriate) than as standalone interventions.
What concerned owners often miss
The alternatives. Corticosteroids — the older standard for atopy — have more significant long-term side effects (organ effects, immune suppression, behavioral changes) than either Apoquel or Cytopoint.
Untreated severe atopy isn't risk-free either. Chronic inflammation has downstream effects. The choice isn't 'treat or not' but 'which treatment, with which supportive layers.'
Common questions about Apoquel and Cytopoint
Can I use both? Some vets do, with specific protocols. Discuss with your vet.
Will my dog need them forever? Some dogs do. Some use them seasonally. Some transition off as immunotherapy or other supportive measures take effect.
Are they safe with supplements? Generally yes — your vet will advise on specifics. Don't combine without vet awareness.
What if my dog doesn't respond? Partial response is common; full non-response is less common. Diagnostic re-evaluation may be needed.
What to track at home
Itching score before and during treatment. Frequency of flare-up episodes. Skin condition photos monthly.
Side effects if any. Quality of life — sleep, play interest, demeanor — often improves alongside symptom reduction.
Where our formulas fit
For atopic dogs on medication, daily allergy-supportive ingredients can complement the medical foundation and may help reduce overall allergic load. For atopic dogs in medication management, our Seasonal Allergy Hemp Chew brings together the four ingredients we'd reach for first in daily allergy support — quercetin paired with bromelain for absorption, colostrum, and a measured hemp dose.
Related reading
The bottom line
If your dog's routine were a portfolio, the foundation positions would be: weight, food, exercise, sleep, and a small number of well-chosen supplements. Speculation goes elsewhere.